Fetalix participated in the EIC Tech to Market Entrepreneurship Programme, an initiative of the European Innovation Council designed to support the commercialization of deep-tech and science-based innovations across Europe.
The programme focuses on helping researchers and early-stage innovators strengthen the entrepreneurial and strategic foundations required to translate advanced technologies into sustainable ventures. Through mentoring, training, and market-oriented activities, participants gain support in areas including business validation, intellectual property, commercialization strategy, and venture development.
Participation in programmes of this nature is particularly relevant for biotechnology startups, where scientific breakthroughs require robust translational pathways and long-term strategic planning to move toward clinical and commercial implementation.
This experience further reinforces Fetalix’s commitment to combining scientific excellence with entrepreneurial development as the company grows.
January 31, 2024
